{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:29:30Z","timestamp":1793532570903,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Hubei Province","award":["2023AFB453"],"award-info":[{"award-number":["2023AFB453"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272718"],"award-info":[{"award-number":["82272718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03395-x","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T08:37:26Z","timestamp":1747903046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Photo-controlled co-delivery of verteporfin and acriflavine via platelets achieves potentiated glioblastoma-targeted photodynamic therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Jie","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Jun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Mei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"10","key":"3395_CR1","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","volume":"23","author":"JP Thakkar","year":"2014","unstructured":"Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, et al. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014;23(10):1985\u201396.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3395_CR2","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.12688\/f1000research.11493.1","volume":"6","author":"F Lieberman","year":"2017","unstructured":"Lieberman F. Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials. F1000Res. 2017;6:1892.","journal-title":"F1000Res"},{"issue":"11","key":"3395_CR3","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/brainsci13111536","volume":"13","author":"RS Angom","year":"2023","unstructured":"Angom RS, Nakka NMR, Bhattacharya S. Advances in glioblastoma therapy: an update on current approaches. Brain Sci. 2023;13(11):1536.","journal-title":"Brain Sci"},{"key":"3395_CR4","doi-asserted-by":"crossref","unstructured":"Lan Z, Li X, Zhang X, Glioblastoma. An update in pathology, molecular mechanisms and biomarkers. Int J Mol Sci. 2024;25(5):3040.","DOI":"10.3390\/ijms25053040"},{"issue":"1","key":"3395_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s44276-024-00051-z","volume":"2","author":"B Gunasegaran","year":"2024","unstructured":"Gunasegaran B, Ashley CL, Marsh-Wakefield F, Guillemin GJ, Heng B. Viruses in glioblastoma: an update on evidence and clinical trials. BJC Rep. 2024;2(1):33.","journal-title":"BJC Rep"},{"issue":"1","key":"3395_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-012-0983-4","volume":"111","author":"K Petrecca","year":"2013","unstructured":"Petrecca K, Guiot MC, Panet-Raymond V, Souhami L. Failure pattern following complete resection plus radiotherapy and Temozolomide is at the resection margin in patients with glioblastoma. J Neuro-Oncol. 2013;111(1):19\u201323.","journal-title":"J Neuro-Oncol"},{"key":"3395_CR7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2147\/OTT.S174316","volume":"12","author":"N Thon","year":"2019","unstructured":"Thon N, Tonn JC, Kreth FW. The surgical perspective in precision treatment of diffuse gliomas. OncoTargets Ther. 2019;12:1497\u2013508.","journal-title":"OncoTargets Ther"},{"key":"3395_CR8","doi-asserted-by":"publisher","first-page":"691697","DOI":"10.3389\/fchem.2021.691697","volume":"9","author":"G Gunaydin","year":"2021","unstructured":"Gunaydin G, Gedik ME, Ayan S. Photodynamic Therapy\u2014Current limitations and novel approaches. Front Chem. 2021;9:691697.","journal-title":"Front Chem"},{"issue":"9","key":"3395_CR9","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/pharmaceutics13091332","volume":"13","author":"JA-O Correia","year":"2021","unstructured":"Correia JA-O, Rodrigues JA-O, Pimenta SA-OX, Dong T, Yang Z. Photodynamic therapy review: principles, photosensitizers, applications, and future directions. Pharmaceutics. 2021;13(9):1332.","journal-title":"Pharmaceutics"},{"key":"3395_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-394306-4.00010-1","volume":"295","author":"JO Yoo","year":"2012","unstructured":"Yoo JO, Ha KS. New insights into the mechanisms for photodynamic therapy-induced cancer cell death. Int Rev Cell Mol Biol. 2012;295:139\u201374.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"1","key":"3395_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5946\/ce.2013.46.1.24","volume":"46","author":"RR Allison","year":"2013","unstructured":"Allison RR, Moghissi K. Photodynamic therapy (PDT): PDT mechanisms. Clin Endosc. 2013;46(1):24\u20139.","journal-title":"Clin Endosc"},{"issue":"7","key":"3395_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc1894","volume":"6","author":"AP Castano","year":"2006","unstructured":"Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006;6(7):535\u201345.","journal-title":"Nat Rev Cancer"},{"key":"3395_CR13","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","volume":"106","author":"S Kwiatkowski","year":"2018","unstructured":"Kwiatkowski S, Knap B, Przystupski D, Saczko J, K\u0119dzierska E, Knap-Czop K, et al. Photodynamic therapy \u2013 mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098\u2013107.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"3395_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers9020019","volume":"9","author":"D Van Straten","year":"2017","unstructured":"Van Straten D, Mashayekhi V, De Bruijn HS, Oliveira S, Robinson DJ. Oncologic photodynamic therapy: basic principles, current clinical status and future directions. Cancers (Basel). 2017;9(2):19.","journal-title":"Cancers (Basel)"},{"key":"3395_CR15","doi-asserted-by":"publisher","first-page":"1250621","DOI":"10.3389\/fchem.2023.1250621","volume":"11","author":"W Domka","year":"2023","unstructured":"Domka W, Bartusik-Aebisher D, Rudy I, Dynarowicz K, Pi\u0119ta K, Aebisher D. Photodynamic therapy in brain cancer: mechanisms, clinical and preclinical studies and therapeutic challenges. Front Chem. 2023;11:1250621.","journal-title":"Front Chem"},{"key":"3395_CR16","doi-asserted-by":"publisher","first-page":"1250699","DOI":"10.3389\/fphar.2023.1250699","volume":"14","author":"D Bartusik-Aebisher","year":"2023","unstructured":"Bartusik-Aebisher D, Serafin I, Dynarowicz K, Aebisher D. Photodynamic therapy and associated targeting methods for treatment of brain cancer. Front Pharmacol. 2023;14:1250699.","journal-title":"Front Pharmacol"},{"key":"3395_CR17","doi-asserted-by":"crossref","unstructured":"Hsia T, Small JL, Yekula A, Batool SM, Escobedo AK, Ekanayake E, et al. Syst Rev Photodynamic Therapy Gliomas Cancers (Basel). 2023;15(15):3918.","DOI":"10.3390\/cancers15153918"},{"issue":"13","key":"3395_CR18","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/cancers15133427","volume":"15","author":"D Bhanja","year":"2023","unstructured":"Bhanja D, Wilding H, Baroz A, Trifoi M, Shenoy G, Slagle-Webb B, et al. Photodynamic therapy for glioblastoma: illuminating the path toward clinical applicability. Cancers (Basel). 2023;15(13):3427.","journal-title":"Cancers (Basel)"},{"key":"3395_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fsurg.2019.00081","volume":"6","author":"SW Cramer","year":"2020","unstructured":"Cramer SW, Chen CC. Photodynamic therapy for the treatment of glioblastoma. Frontiers in surgery. Front Surg. 2020;6:81.","journal-title":"Front Surg"},{"key":"3395_CR20","doi-asserted-by":"publisher","first-page":"1080685","DOI":"10.3389\/fonc.2022.1080685","volume":"12","author":"A Ferr\u00e9s","year":"2022","unstructured":"Ferr\u00e9s A, Di Somma A, Mosteiro A, Topczewski TE, Rold\u00e1n P, Pedrosa L, et al. Photodynamic therapy in glioblastoma: detection of intraoperative inadvertent 5-ALA mediated photodynamic therapeutical effect after gross total resection. Front Oncol. 2022;12:1080685.","journal-title":"Front Oncol"},{"issue":"6","key":"3395_CR21","doi-asserted-by":"publisher","first-page":"E414","DOI":"10.1093\/neuros\/nyy324","volume":"84","author":"C Dupont","year":"2019","unstructured":"Dupont C, Vermandel M, Leroy HA, Quidet M, Lecomte F, Delhem N, et al. INtraoperative photodynamic therapy for glioblastomas (INDYGO): study protocol for a phase I clinical trial. Neurosurgery. 2019;84(6):E414\u20139.","journal-title":"Neurosurgery"},{"issue":"9","key":"3395_CR22","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3390\/cancers15092603","volume":"15","author":"M Foglar","year":"2023","unstructured":"Foglar M, Aumiller M, Bochmann K, Buchner A, El Fahim M, Quach S, et al. Interstitial photodynamic therapy of glioblastomas: A Long-Term Follow-up analysis of survival and volumetric MRI data. Cancers (Basel). 2023;15(9):2603.","journal-title":"Cancers (Basel)"},{"key":"3395_CR23","doi-asserted-by":"publisher","first-page":"100161","DOI":"10.1016\/j.jpap.2023.100161","volume":"13","author":"M Miretti","year":"2023","unstructured":"Miretti M, Gonz\u00e1lez Graglia MA, Su\u00e1rez AI, Prucca CG. Photodynamic therapy for glioblastoma: A light at the end of the tunnel. J Photochem Photobiol. 2023;13:100161.","journal-title":"J Photochem Photobiol"},{"issue":"4","key":"3395_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/cells13040336","volume":"13","author":"GL Liguori","year":"2024","unstructured":"Liguori GL. Challenges and promise for glioblastoma treatment through extracellular vesicle inquiry. Cells. 2024;13(4):336.","journal-title":"Cells"},{"key":"3395_CR25","doi-asserted-by":"publisher","first-page":"557429","DOI":"10.3389\/fphar.2020.557429","volume":"11","author":"C Wei","year":"2020","unstructured":"Wei C, Li X. The role of photoactivated and Non-Photoactivated verteporfin on tumor. Front Pharmacol. 2020;11:557429.","journal-title":"Front Pharmacol"},{"issue":"17","key":"3395_CR26","doi-asserted-by":"publisher","first-page":"11415","DOI":"10.1021\/acs.jmedchem.2c00573","volume":"65","author":"K Piorecka","year":"2022","unstructured":"Piorecka K, Kurjata J, Stanczyk WA. Acriflavine, an acridine derivative for biomedical application: current state of the Art. J Med Chem. 2022;65(17):11415\u201332.","journal-title":"J Med Chem"},{"issue":"12","key":"3395_CR27","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995;92(12):5510\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3395_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/gad.12.2.149","volume":"12","author":"NV Iyer","year":"1998","unstructured":"Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998;12(2):149\u201362.","journal-title":"Genes Dev"},{"issue":"17","key":"3395_CR29","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1056\/NEJMcibr1610065","volume":"375","author":"MC Simon","year":"2016","unstructured":"Simon MC. The hypoxia response Pathways - Hats off! N Engl J Med. 2016;375(17):1687\u20139.","journal-title":"N Engl J Med"},{"issue":"Supplement7","key":"3395_CR30","first-page":"vii91","volume":"24","author":"K Bhat","year":"2022","unstructured":"Bhat K, Bhat K, Tang T. DNAR-05. A ROLE FOR TAZ\/YAP IN DNA DAMAGE REPAIR IN GLIOBLASTOMA. Neurooncology. 2022;24(Supplement7):vii91\u2013vii.","journal-title":"Neurooncology"},{"issue":"8","key":"3395_CR31","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/febs.13604","volume":"283","author":"DE Pefani","year":"2016","unstructured":"Pefani DE, O\u2019Neill E. Hippo pathway and protection of genome stability in response to DNA damage. FEBS J. 2016;283(8):1392\u2013403.","journal-title":"FEBS J"},{"issue":"8","key":"3395_CR32","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1073\/pnas.0708670105","volume":"105","author":"K Tan","year":"2008","unstructured":"Tan K, Feizi H, Luo C, Fan SH, Ravasi T, Ideker TG. A systems approach to delineate functions of paralogous transcription factors: role of the Yap family in the DNA damage response. Proc Natl Acad Sci U S A. 2008;105(8):2934\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3395_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41420-023-01687-5","volume":"9","author":"H-A Chang","year":"2023","unstructured":"Chang H-A, Ou Yang R-Z, Su J-M, Nguyen TMH, Sung J-M, Tang M-J, et al. YAP nuclear translocation induced by HIF-1\u03b1 prevents DNA damage under hypoxic conditions. Cell Death Discov. 2023;9(1):385.","journal-title":"Cell Death Discov"},{"issue":"15","key":"3395_CR34","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.3390\/cancers13153833","volume":"13","author":"A-S Wozny","year":"2021","unstructured":"Wozny A-S, Gauthier A, Alphonse G, Mal\u00e9sys C, Varoclier V, Beuve M, et al. Involvement of HIF-1\u03b1 in the detection, signaling, and repair of DNA Double-Strand breaks after photon and Carbon-Ion irradiation. Cancers (Basel). 2021;13(15):3833.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"3395_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/15384101.2017.1302208","volume":"16","author":"AH Rezaeian","year":"2017","unstructured":"Rezaeian AH, Wang YH, Lin HK. DNA damage players are linked to HIF-1\u03b1\/hypoxia signaling. Cell Cycle. 2017;16(8):725\u20136.","journal-title":"Cell Cycle"},{"issue":"4","key":"3395_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10555-015-9588-7","volume":"34","author":"M Broekgaarden","year":"2015","unstructured":"Broekgaarden M, Weijer R, van Gulik TM, Hamblin MR, Heger M. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for Pharmacological Inhibition strategies. Cancer Metastasis Rev. 2015;34(4):643\u201390.","journal-title":"Cancer Metastasis Rev"},{"key":"3395_CR37","doi-asserted-by":"publisher","first-page":"121833","DOI":"10.1016\/j.biomaterials.2022.121833","volume":"290","author":"HZ Xu","year":"2022","unstructured":"Xu HZ, Li TF, Ma Y, Li K, Zhang Q, Xu YH, et al. Targeted photodynamic therapy of glioblastoma mediated by platelets with photo-controlled release property. Biomaterials. 2022;290:121833.","journal-title":"Biomaterials"},{"issue":"12","key":"3395_CR38","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.3390\/cancers12123847","volume":"12","author":"S Morice","year":"2020","unstructured":"Morice S, Mullard M, Brion R, Dupuy M, Renault S, Tesfaye R, et al. The YAP\/TEAD Axis as a new therapeutic target in osteosarcoma: effect of verteporfin and CA3 on primary tumor growth. Cancers (Basel). 2020;12(12):3847.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3395_CR39","first-page":"27","volume":"6","author":"C Wang","year":"2016","unstructured":"Wang C, Zhu X, Feng W, Yu Y, Jeong K, Guo W, et al. Verteporfin inhibits YAP function through up-regulating 14-3-3\u03c3 sequestering YAP in the cytoplasm. Am J Cancer Res. 2016;6(1):27\u201337.","journal-title":"Am J Cancer Res"},{"issue":"18","key":"3395_CR40","doi-asserted-by":"publisher","first-page":"15911","DOI":"10.1074\/jbc.M300463200","volume":"278","author":"Y Yuan","year":"2003","unstructured":"Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem. 2003;278(18):15911\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"3395_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30(1):1\u201317.","journal-title":"Genes Dev"},{"issue":"1","key":"3395_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.7150\/ijbs.75459","volume":"19","author":"H Song","year":"2023","unstructured":"Song H, Qiu Z, Wang Y, Xi C, Zhang G, Sun Z, et al. HIF-1\u03b1\/YAP signaling rewrites glucose\/iodine metabolism program to promote papillary thyroid Cancer progression. Int J Biol Sci. 2023;19(1):225\u201341.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"3395_CR43","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/cbin.11246","volume":"44","author":"B Zhu","year":"2020","unstructured":"Zhu B, Pan S, Liu J, Wang S, Ni Y, Xiao L, et al. HIF-1\u03b1 forms regulatory loop with YAP to coordinate hypoxia-induced adriamycin resistance in acute myeloid leukemia cells. Cell Biol Int. 2020;44(2):456\u201366.","journal-title":"Cell Biol Int"},{"key":"3395_CR44","doi-asserted-by":"crossref","unstructured":"Blackford AN, Jackson SP, ATM, ATR. The trinity at the heart of the DNA damage response. Mol Cell. 2017;66(6):801\u201317.","DOI":"10.1016\/j.molcel.2017.05.015"},{"issue":"9","key":"3395_CR45","doi-asserted-by":"publisher","first-page":"a012716","DOI":"10.1101\/cshperspect.a012716","volume":"5","author":"A Mar\u00e9chal","year":"2013","unstructured":"Mar\u00e9chal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol. 2013;5(9):a012716.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"3395_CR46","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3390\/ijms22041981","volume":"22","author":"S Raja","year":"2021","unstructured":"Raja S, Van Houten B. The multiple cellular roles of SMUG1 in genome maintenance and Cancer. Int J Mol Sci. 2021;22(4):1981.","journal-title":"Int J Mol Sci"},{"issue":"39","key":"3395_CR47","doi-asserted-by":"publisher","first-page":"24257","DOI":"10.1074\/jbc.271.39.24257","volume":"271","author":"P Robins","year":"1996","unstructured":"Robins P, Lindahl T. DNA ligase IV from HeLa cell nuclei. J Biol Chem. 1996;271(39):24257\u201361.","journal-title":"J Biol Chem"},{"issue":"2","key":"3395_CR48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","volume":"36","author":"M Holinstat","year":"2017","unstructured":"Holinstat M. Normal platelet function. Cancer Metastasis Rev. 2017;36(2):195\u20138.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"3395_CR49","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.3390\/ijms24054565","volume":"24","author":"C Puricelli","year":"2023","unstructured":"Puricelli C, Boggio E, Gigliotti CL, Stoppa I, Sutti S, Giordano M, et al. Platelets, protean cells with All-Around functions and multifaceted Pharmacological applications. Int J Mol Sci. 2023;24(5):4565.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3395_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1083\/jcb.111.1.79","volume":"111","author":"T Morimoto","year":"1990","unstructured":"Morimoto T, Ogihara S, Takisawa H. Anchorage of secretion-competent dense granules on the plasma membrane of bovine platelets in the absence of secretory stimulation. J Cell Biol. 1990;111(1):79\u201386.","journal-title":"J Cell Biol"},{"issue":"7","key":"3395_CR51","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.83.7.2076","volume":"83","author":"DA Deranleau","year":"1986","unstructured":"Deranleau DA, L\u00fcthy R, L\u00fcscher EF. Stochastic response of human blood platelets to stimulation of shape changes and secretion. Proc Natl Acad Sci U S A. 1986;83(7):2076\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3395_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/mps6040072","volume":"6","author":"I Eriksson","year":"2023","unstructured":"Eriksson I, Vainikka L, Persson HL, \u00d6llinger K. Real-Time monitoring of lysosomal membrane permeabilization using acridine orange. Methods Protoc. 2023;6(4):72.","journal-title":"Methods Protoc"},{"key":"3395_CR53","doi-asserted-by":"publisher","first-page":"236","DOI":"10.12688\/f1000research.13283.1","volume":"7","author":"A Sharda","year":"2018","unstructured":"Sharda A, Flaumenhaft R. The life cycle of platelet granules. F1000Res. 2018;7:236.","journal-title":"F1000Res"},{"issue":"1","key":"3395_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pdpdt.2012.08.004","volume":"10","author":"MO Senge","year":"2013","unstructured":"Senge MO, Radomski MW. Platelets, photosensitizers, and PDT. Photodiagnosis Photodyn Ther. 2013;10(1):1\u201316.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"3395_CR55","doi-asserted-by":"publisher","first-page":"849040","DOI":"10.3389\/fgene.2022.849040","volume":"13","author":"A Sharma","year":"2022","unstructured":"Sharma A, Sinha S, Shrivastava N. Therapeutic targeting Hypoxia-Inducible factor (HIF-1) in cancer: cutting gordian knot of Cancer cell metabolism. Front Genet. 2022;13:849040.","journal-title":"Front Genet"},{"issue":"11","key":"3395_CR56","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.3390\/ijms22115703","volume":"22","author":"V Infantino","year":"2021","unstructured":"Infantino V, Santarsiero A, Convertini P, Todisco S, Iacobazzi V. Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target. Int J Mol Sci. 2021;22(11):5703.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3395_CR57","doi-asserted-by":"publisher","first-page":"e159839","DOI":"10.1172\/JCI159839","volume":"132","author":"EE Wicks","year":"2022","unstructured":"Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest. 2022;132(11):e159839.","journal-title":"J Clin Invest"},{"issue":"1","key":"3395_CR58","doi-asserted-by":"publisher","first-page":"18962","DOI":"10.1038\/s41598-022-23060-9","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang S, Hu H, Li X. A systematic study of HIF1A cofactors in hypoxic cancer cells. Sci Rep. 2022;12(1):18962.","journal-title":"Sci Rep"},{"issue":"1","key":"3395_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13046-023-02704-2","volume":"42","author":"J Luo","year":"2023","unstructured":"Luo J, Deng L, Zou H, Guo Y, Tong T, Huang M, et al. New insights into the ambivalent role of YAP\/TAZ in human cancers. J Exp Clin Cancer Res. 2023;42(1):130.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3395_CR60","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1038\/s41467-023-39527-w","volume":"14","author":"IAM Barbosa","year":"2023","unstructured":"Barbosa IAM, Gopalakrishnan R, Mercan S, Mourikis TP, Martin T, Wengert S, et al. Cancer lineage-specific regulation of YAP responsive elements revealed through large-scale functional epigenomic screens. Nat Commun. 2023;14(1):3907.","journal-title":"Nat Commun"},{"issue":"1","key":"3395_CR61","first-page":"9","volume":"4","author":"S Piccolo","year":"2023","unstructured":"Piccolo S, Panciera T, Contessotto P, Cordenonsi M. YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer. 2023;4(1):9\u201326.","journal-title":"Nat Cancer"},{"issue":"1","key":"3395_CR62","first-page":"16","volume":"40","author":"H Liu","year":"2018","unstructured":"Liu H, Du S, Lei T, Wang H, He X, Tong R, et al. Multifaceted regulation and functions of YAP\/TAZ in tumors (Review). Oncol Rep. 2018;40(1):16\u201328.","journal-title":"Oncol Rep"},{"issue":"15","key":"3395_CR63","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1074\/jbc.M115.700823","volume":"291","author":"S Wang","year":"2016","unstructured":"Wang S, Lu Y, Yin MX, Wang C, Wu W, Li J, et al. Importin \u03911 mediates yorkie nuclear import via an N-terminal Non-canonical nuclear localization signal. J Biol Chem. 2016;291(15):7926\u201337.","journal-title":"J Biol Chem"},{"issue":"1","key":"3395_CR64","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1186\/s12885-020-07555-0","volume":"20","author":"C Wei","year":"2020","unstructured":"Wei C, Li X. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation. BMC Cancer. 2020;20(1):1042.","journal-title":"BMC Cancer"},{"issue":"6","key":"3395_CR65","first-page":"3181","volume":"42","author":"H Li","year":"2018","unstructured":"Li H, Li X, Jing X, Li M, Ren Y, Chen J, et al. Hypoxia promotes maintenance of the chondrogenic phenotype in rat growth plate chondrocytes through the HIF-1\u03b1\/YAP signaling pathway. Int J Mol Med. 2018;42(6):3181\u201392.","journal-title":"Int J Mol Med"},{"issue":"6","key":"3395_CR66","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nphoton.2014.90","volume":"8","author":"AV Kachynski","year":"2014","unstructured":"Kachynski AV, Pliss A, Kuzmin AN, Ohulchanskyy TY, Baev A, Qu J, et al. Photodynamic therapy by in situ nonlinear photon conversion. Nat Photonics. 2014;8(6):455\u201361.","journal-title":"Nat Photonics"},{"issue":"1","key":"3395_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cplett.2004.03.136","volume":"390","author":"PD Zhao","year":"2004","unstructured":"Zhao PD, Chen P, Tang GQ, Zhang GL, Chen WJ. Two-photon spectroscopic properties of a new Chlorin derivative photosensitizer. Chem Phys Lett. 2004;390(1):41\u20134.","journal-title":"Chem Phys Lett"},{"issue":"18","key":"3395_CR68","doi-asserted-by":"publisher","first-page":"10992","DOI":"10.1039\/C6RA28616J","volume":"7","author":"H Gattuso","year":"2017","unstructured":"Gattuso H, Monari A, Marazzi M. Photophysics of Chlorin e6: from one- and two-photon absorption to fluorescence and phosphorescence. RSC Adv. 2017;7(18):10992\u20139.","journal-title":"RSC Adv"},{"key":"3395_CR69","doi-asserted-by":"publisher","first-page":"122913","DOI":"10.1016\/j.biomaterials.2024.122913","volume":"315","author":"M-F Wang","year":"2025","unstructured":"Wang M-F, Guo J, Yuan S-J, Li K, Zhang Q, Lei H-M, et al. Targeted sonodynamic therapy induces tumor cell quasi-immunogenic ferroptosis and macrophage immunostimulatory autophagy in glioblastoma. Biomaterials. 2025;315:122913.","journal-title":"Biomaterials"},{"issue":"1","key":"3395_CR70","doi-asserted-by":"publisher","first-page":"2219429","DOI":"10.1080\/10717544.2023.2219429","volume":"30","author":"M Wang","year":"2023","unstructured":"Wang M, Xu H, Li T, Li K, Zhang Q, Chen S, et al. Sonodynamic therapy of glioblastoma mediated by platelets with ultrasound-triggered drug release. Drug Delivery. 2023;30(1):2219429.","journal-title":"Drug Delivery"},{"issue":"1","key":"3395_CR71","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11060-023-04284-9","volume":"162","author":"S Quach","year":"2023","unstructured":"Quach S, Schwartz C, Aumiller M, Foglar M, Schmutzer M, Katzendobler S, et al. Interstitial photodynamic therapy for newly diagnosed glioblastoma. J Neurooncol. 2023;162(1):217\u201323.","journal-title":"J Neurooncol"},{"key":"3395_CR72","doi-asserted-by":"publisher","first-page":"102492","DOI":"10.1016\/j.pdpdt.2021.102492","volume":"36","author":"HA Leroy","year":"2021","unstructured":"Leroy HA, Gu\u00e9rin L, Lecomte F, Baert G, Vignion AS, Mordon S, et al. Is interstitial photodynamic therapy for brain tumors ready for clinical practice? A systematic review. Photodiagnosis Photodyn Ther. 2021;36:102492.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"3395_CR73","doi-asserted-by":"crossref","unstructured":"Ozawa T, James CD. Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging. J Visualized Exp. 2010;41:1986.","DOI":"10.3791\/1986-v"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03395-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03395-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03395-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:03:43Z","timestamp":1747908223000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03395-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3395"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03395-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}